 | • レポートコード：GIR-107A14314 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腎臓がん治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腎臓がん治療薬の種類別市場規模（血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2））、用途別市場規模（病院、研究所、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腎臓がん治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen/Allergan、Argos Therapeutics、AstraZeneca、Aveo Pharmaceuticals、Bayer、Exelixis、Incyte、Merck、Roche、Pfizer、Bristol-Myers Squibb、Eisai、Prometheus Labs、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2） ・用途別分析2016年-2026年：病院、研究所、診断センター、その他 ・腎臓がん治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腎臓がん治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腎臓がん治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腎臓がん治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腎臓がん治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Kidney Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Kidney Cancer Treatment Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Kidney Cancer Treatment Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Kidney Cancer Treatment Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Market segment by Application can be divided into
Hospitals
Research Institutes
Diagnostic Centers
Others
The key market players for global Kidney Cancer Treatment Drugs market are listed below:
Amgen/Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Pfizer
Bristol-Myers Squibb
Eisai
Prometheus Labs
Novartis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Kidney Cancer Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney Cancer Treatment Drugs, with price, sales, revenue and global market share of Kidney Cancer Treatment Drugs from 2019 to 2021.
Chapter 3, the Kidney Cancer Treatment Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney Cancer Treatment Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Kidney Cancer Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Kidney Cancer Treatment Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Kidney Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney Cancer Treatment Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Angiogenesis Inhibitors
1.2.3 mTOR Inhibitors
1.2.4 Monoclonal Antibodies
1.2.5 Cytokine Immunotherapy (IL-2)
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney Cancer Treatment Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Global Kidney Cancer Treatment Drugs Market Size & Forecast
1.4.1 Global Kidney Cancer Treatment Drugs Sales in Value (2016-2026))
1.4.2 Global Kidney Cancer Treatment Drugs Sales in Volume (2016-2026)
1.4.3 Global Kidney Cancer Treatment Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Kidney Cancer Treatment Drugs Production Capacity Analysis
1.5.1 Global Kidney Cancer Treatment Drugs Total Production Capacity (2016-2026)
1.5.2 Global Kidney Cancer Treatment Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Kidney Cancer Treatment Drugs Market Drivers
1.6.2 Kidney Cancer Treatment Drugs Market Restraints
1.6.3 Kidney Cancer Treatment Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen/Allergan
2.1.1 Amgen/Allergan Details
2.1.2 Amgen/Allergan Major Business
2.1.3 Amgen/Allergan Kidney Cancer Treatment Drugs Product and Services
2.1.4 Amgen/Allergan Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Argos Therapeutics
2.2.1 Argos Therapeutics Details
2.2.2 Argos Therapeutics Major Business
2.2.3 Argos Therapeutics Kidney Cancer Treatment Drugs Product and Services
2.2.4 Argos Therapeutics Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Kidney Cancer Treatment Drugs Product and Services
2.3.4 AstraZeneca Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Aveo Pharmaceuticals
2.4.1 Aveo Pharmaceuticals Details
2.4.2 Aveo Pharmaceuticals Major Business
2.4.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product and Services
2.4.4 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Kidney Cancer Treatment Drugs Product and Services
2.5.4 Bayer Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Exelixis
2.6.1 Exelixis Details
2.6.2 Exelixis Major Business
2.6.3 Exelixis Kidney Cancer Treatment Drugs Product and Services
2.6.4 Exelixis Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Incyte
2.7.1 Incyte Details
2.7.2 Incyte Major Business
2.7.3 Incyte Kidney Cancer Treatment Drugs Product and Services
2.7.4 Incyte Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Kidney Cancer Treatment Drugs Product and Services
2.8.4 Merck Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business
2.9.3 Roche Kidney Cancer Treatment Drugs Product and Services
2.9.4 Roche Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Kidney Cancer Treatment Drugs Product and Services
2.10.4 Pfizer Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Bristol-Myers Squibb
2.11.1 Bristol-Myers Squibb Details
2.11.2 Bristol-Myers Squibb Major Business
2.11.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product and Services
2.11.4 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Eisai
2.12.1 Eisai Details
2.12.2 Eisai Major Business
2.12.3 Eisai Kidney Cancer Treatment Drugs Product and Services
2.12.4 Eisai Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Prometheus Labs
2.13.1 Prometheus Labs Details
2.13.2 Prometheus Labs Major Business
2.13.3 Prometheus Labs Kidney Cancer Treatment Drugs Product and Services
2.13.4 Prometheus Labs Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Kidney Cancer Treatment Drugs Product and Services
2.14.4 Novartis Kidney Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Kidney Cancer Treatment Drugs Sales by Manufacturer
3.1 Global Kidney Cancer Treatment Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Kidney Cancer Treatment Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Kidney Cancer Treatment Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Kidney Cancer Treatment Drugs Manufacturer Market Share
3.4.2 Top 6 Kidney Cancer Treatment Drugs Manufacturer Market Share
3.5 Global Kidney Cancer Treatment Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Kidney Cancer Treatment Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Kidney Cancer Treatment Drugs Market Size by Region
4.1.1 Global Kidney Cancer Treatment Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Kidney Cancer Treatment Drugs Revenue by Region (2016-2026)
4.2 North America Kidney Cancer Treatment Drugs Revenue (2016-2026)
4.3 Europe Kidney Cancer Treatment Drugs Revenue (2016-2026)
4.4 Asia-Pacific Kidney Cancer Treatment Drugs Revenue (2016-2026)
4.5 South America Kidney Cancer Treatment Drugs Revenue (2016-2026)
4.6 Middle East and Africa Kidney Cancer Treatment Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Kidney Cancer Treatment Drugs Sales in Volume by Type (2016-2026)
5.2 Global Kidney Cancer Treatment Drugs Revenue by Type (2016-2026)
5.3 Global Kidney Cancer Treatment Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Kidney Cancer Treatment Drugs Sales in Volume by Application (2016-2026)
6.2 Global Kidney Cancer Treatment Drugs Revenue by Application (2016-2026)
6.3 Global Kidney Cancer Treatment Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Kidney Cancer Treatment Drugs Sales by Type (2016-2026)
7.2 North America Kidney Cancer Treatment Drugs Sales by Application (2016-2026)
7.3 North America Kidney Cancer Treatment Drugs Market Size by Country
7.3.1 North America Kidney Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Kidney Cancer Treatment Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Kidney Cancer Treatment Drugs Sales by Type (2016-2026)
8.2 Europe Kidney Cancer Treatment Drugs Sales by Application (2016-2026)
8.3 Europe Kidney Cancer Treatment Drugs Market Size by Country
8.3.1 Europe Kidney Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Kidney Cancer Treatment Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Kidney Cancer Treatment Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Kidney Cancer Treatment Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Kidney Cancer Treatment Drugs Market Size by Region
9.3.1 Asia-Pacific Kidney Cancer Treatment Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Kidney Cancer Treatment Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Kidney Cancer Treatment Drugs Sales by Type (2016-2026)
10.2 South America Kidney Cancer Treatment Drugs Sales by Application (2016-2026)
10.3 South America Kidney Cancer Treatment Drugs Market Size by Country
10.3.1 South America Kidney Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Kidney Cancer Treatment Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Kidney Cancer Treatment Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Kidney Cancer Treatment Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Kidney Cancer Treatment Drugs Market Size by Country
11.3.1 Middle East & Africa Kidney Cancer Treatment Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Kidney Cancer Treatment Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Kidney Cancer Treatment Drugs Typical Distributors
12.3 Kidney Cancer Treatment Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Kidney Cancer Treatment Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Kidney Cancer Treatment Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen/Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Amgen/Allergan Major Business
Table 5. Amgen/Allergan Kidney Cancer Treatment Drugs Product and Services
Table 6. Amgen/Allergan Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Argos Therapeutics Major Business
Table 9. Argos Therapeutics Kidney Cancer Treatment Drugs Product and Services
Table 10. Argos Therapeutics Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Kidney Cancer Treatment Drugs Product and Services
Table 14. AstraZeneca Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Aveo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Aveo Pharmaceuticals Major Business
Table 17. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product and Services
Table 18. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Kidney Cancer Treatment Drugs Product and Services
Table 22. Bayer Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Exelixis Basic Information, Manufacturing Base and Competitors
Table 24. Exelixis Major Business
Table 25. Exelixis Kidney Cancer Treatment Drugs Product and Services
Table 26. Exelixis Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Incyte Basic Information, Manufacturing Base and Competitors
Table 28. Incyte Major Business
Table 29. Incyte Kidney Cancer Treatment Drugs Product and Services
Table 30. Incyte Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Kidney Cancer Treatment Drugs Product and Services
Table 34. Merck Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Roche Basic Information, Manufacturing Base and Competitors
Table 36. Roche Major Business
Table 37. Roche Kidney Cancer Treatment Drugs Product and Services
Table 38. Roche Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Kidney Cancer Treatment Drugs Product and Services
Table 42. Pfizer Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 44. Bristol-Myers Squibb Major Business
Table 45. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product and Services
Table 46. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Eisai Basic Information, Manufacturing Base and Competitors
Table 48. Eisai Major Business
Table 49. Eisai Kidney Cancer Treatment Drugs Product and Services
Table 50. Eisai Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Prometheus Labs Basic Information, Manufacturing Base and Competitors
Table 52. Prometheus Labs Major Business
Table 53. Prometheus Labs Kidney Cancer Treatment Drugs Product and Services
Table 54. Prometheus Labs Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Major Business
Table 57. Novartis Kidney Cancer Treatment Drugs Product and Services
Table 58. Novartis Kidney Cancer Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Kidney Cancer Treatment Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Kidney Cancer Treatment Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Kidney Cancer Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Kidney Cancer Treatment Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Kidney Cancer Treatment Drugs Production Site of Key Manufacturer
Table 64. Kidney Cancer Treatment Drugs New Entrant and Capacity Expansion Plans
Table 65. Kidney Cancer Treatment Drugs Mergers & Acquisitions in the Past Five Years
Table 66. Global Kidney Cancer Treatment Drugs Sales by Region (2016-2021e) & (K Units)
Table 67. Global Kidney Cancer Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 68. Global Kidney Cancer Treatment Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Kidney Cancer Treatment Drugs Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Kidney Cancer Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 71. Global Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 72. Global Kidney Cancer Treatment Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Kidney Cancer Treatment Drugs Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Kidney Cancer Treatment Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 75. Global Kidney Cancer Treatment Drugs Price by Type (2021-2026) & (USD/Unit)
Table 76. Global Kidney Cancer Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 77. Global Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 78. Global Kidney Cancer Treatment Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Kidney Cancer Treatment Drugs Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Kidney Cancer Treatment Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 81. Global Kidney Cancer Treatment Drugs Price by Application (2021-2026) & (USD/Unit)
Table 82. North America Kidney Cancer Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 83. North America Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 84. North America Kidney Cancer Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Kidney Cancer Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Kidney Cancer Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 87. North America Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 88. North America Kidney Cancer Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 89. North America Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 90. Europe Kidney Cancer Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 91. Europe Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 92. Europe Kidney Cancer Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Kidney Cancer Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Kidney Cancer Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 95. Europe Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 96. Europe Kidney Cancer Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 97. Europe Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 98. Asia-Pacific Kidney Cancer Treatment Drugs Sales by Region (2016-2021e) & (K Units)
Table 99. Asia-Pacific Kidney Cancer Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 100. Asia-Pacific Kidney Cancer Treatment Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Kidney Cancer Treatment Drugs Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Kidney Cancer Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 103. Asia-Pacific Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 104. Asia-Pacific Kidney Cancer Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 105. Asia-Pacific Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 106. South America Kidney Cancer Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 107. South America Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 108. South America Kidney Cancer Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Kidney Cancer Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Kidney Cancer Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 111. South America Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 112. South America Kidney Cancer Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 113. South America Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 114. Middle East & Africa Kidney Cancer Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 115. Middle East & Africa Kidney Cancer Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 116. Middle East & Africa Kidney Cancer Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Kidney Cancer Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Kidney Cancer Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 119. Middle East & Africa Kidney Cancer Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 120. Middle East & Africa Kidney Cancer Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 121. Middle East & Africa Kidney Cancer Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Kidney Cancer Treatment Drugs Typical Distributors
Table 125. Kidney Cancer Treatment Drugs Typical Customers
List of Figures
Figure 1. Kidney Cancer Treatment Drugs Picture
Figure 2. Global Kidney Cancer Treatment Drugs Sales Market Share by Type in 2020
Figure 3. Angiogenesis Inhibitors
Figure 4. mTOR Inhibitors
Figure 5. Monoclonal Antibodies
Figure 6. Cytokine Immunotherapy (IL-2)
Figure 7. Global Kidney Cancer Treatment Drugs Sales Market Share by Application in 2020
Figure 8. Hospitals
Figure 9. Research Institutes
Figure 10. Diagnostic Centers
Figure 11. Others
Figure 12. Global Kidney Cancer Treatment Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Kidney Cancer Treatment Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Kidney Cancer Treatment Drugs Sales (2016-2026) & (K Units)
Figure 15. Global Kidney Cancer Treatment Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Kidney Cancer Treatment Drugs Production Capacity (2016-2026) & (K Units)
Figure 17. Global Kidney Cancer Treatment Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Kidney Cancer Treatment Drugs Market Drivers
Figure 19. Kidney Cancer Treatment Drugs Market Restraints
Figure 20. Kidney Cancer Treatment Drugs Market Trends
Figure 21. Global Kidney Cancer Treatment Drugs Sales Market Share by Manufacturer in 2020
Figure 22. Global Kidney Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2020
Figure 23. Kidney Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Kidney Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Kidney Cancer Treatment Drugs Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Kidney Cancer Treatment Drugs Sales Market Share by Region (2016-2026)
Figure 27. Global Kidney Cancer Treatment Drugs Revenue Market Share by Region (2016-2026)
Figure 28. North America Kidney Cancer Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Europe Kidney Cancer Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Kidney Cancer Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 31. South America Kidney Cancer Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Kidney Cancer Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Global Kidney Cancer Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 34. Global Kidney Cancer Treatment Drugs Revenue Market Share by Type (2016-2026)
Figure 35. Global Kidney Cancer Treatment Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Kidney Cancer Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 37. Global Kidney Cancer Treatment Drugs Revenue Market Share by Application (2016-2026)
Figure 38. Global Kidney Cancer Treatment Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Kidney Cancer Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 40. North America Kidney Cancer Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 41. North America Kidney Cancer Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 42. North America Kidney Cancer Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 43. United States Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Kidney Cancer Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 47. Europe Kidney Cancer Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 48. Europe Kidney Cancer Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 49. Europe Kidney Cancer Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Kidney Cancer Treatment Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Kidney Cancer Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Kidney Cancer Treatment Drugs Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Kidney Cancer Treatment Drugs Revenue Market Share by Region (2016-2026)
Figure 59. China Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Kidney Cancer Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 66. South America Kidney Cancer Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Kidney Cancer Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Kidney Cancer Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Kidney Cancer Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Kidney Cancer Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Kidney Cancer Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Kidney Cancer Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Kidney Cancer Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の卵巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Ovarian Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界の肺がん治療薬市場 2021：企業別、地域別、種類・用途別 The Lung Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の慢性腎疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Chronic Kidney Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の腎臓がん治療・診断市場 2021：企業別、地域別、種類・用途別 The Kidney Cancer Therapeutics and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界の末期腎疾患治療市場 2021：企業別、地域別、種類・用途別 The End-Stage Kidney Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…